Literature DB >> 34354262

Accelerated RNA detection using tandem CRISPR nucleases.

Tina Y Liu1,2, Gavin J Knott1,2,3, Dylan C J Smock1,2, John J Desmarais1, Sungmin Son4, Abdul Bhuiya4,5, Shrutee Jakhanwal1,2, Noam Prywes2, Shreeya Agrawal2,4, María Díaz de León Derby4,5, Neil A Switz6, Maxim Armstrong7, Andrew R Harris4, Emeric J Charles1, Brittney W Thornton1, Parinaz Fozouni8,9,10,11, Jeffrey Shu8,11, Stephanie I Stephens8,11, G Renuka Kumar8,11, Chunyu Zhao8,12, Amanda Mok13, Anthony T Iavarone14, Arturo M Escajeda15, Roger McIntosh15, Shineui Kim1,2, Eli J Dugan1,2, Katherine S Pollard8,12,16, Ming X Tan13, Melanie Ott8,11, Daniel A Fletcher4,5,12,17, Liana F Lareau2,4, Patrick D Hsu18,19,20,21,22, David F Savage23,24, Jennifer A Doudna25,26,27,28,29,30,31.   

Abstract

Direct, amplification-free detection of RNA has the potential to transform molecular diagnostics by enabling simple on-site analysis of human or environmental samples. CRISPR-Cas nucleases offer programmable RNA-guided RNA recognition that triggers cleavage and release of a fluorescent reporter molecule, but long reaction times hamper their detection sensitivity and speed. Here, we show that unrelated CRISPR nucleases can be deployed in tandem to provide both direct RNA sensing and rapid signal generation, thus enabling robust detection of ~30 molecules per µl of RNA in 20 min. Combining RNA-guided Cas13 and Csm6 with a chemically stabilized activator creates a one-step assay that can detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA extracted from respiratory swab samples with quantitative reverse transcriptase PCR (qRT-PCR)-derived cycle threshold (Ct) values up to 33, using a compact detector. This Fast Integrated Nuclease Detection In Tandem (FIND-IT) approach enables sensitive, direct RNA detection in a format that is amenable to point-of-care infection diagnosis as well as to a wide range of other diagnostic or research applications.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Year:  2021        PMID: 34354262     DOI: 10.1038/s41589-021-00842-2

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  27 in total

Review 1.  Point-of-care diagnostics: recent developments in a pandemic age.

Authors:  Harshit Harpaldas; Siddarth Arumugam; Chelsey Campillo Rodriguez; Bhoomika Ajay Kumar; Vivian Shi; Samuel K Sia
Journal:  Lab Chip       Date:  2021-11-25       Impact factor: 6.799

2.  Enhancement of CRISPR/Cas12a trans-cleavage activity using hairpin DNA reporters.

Authors:  Marianna Rossetti; Rosa Merlo; Neda Bagheri; Danila Moscone; Anna Valenti; Aakash Saha; Pablo R Arantes; Rudy Ippodrino; Francesco Ricci; Ida Treglia; Elisabetta Delibato; John van der Oost; Giulia Palermo; Giuseppe Perugino; Alessandro Porchetta
Journal:  Nucleic Acids Res       Date:  2022-08-12       Impact factor: 19.160

3.  Engineered LwaCas13a with enhanced collateral activity for nucleic acid detection.

Authors:  Jie Yang; Yang Song; Xiangyu Deng; Jeffrey A Vanegas; Zheng You; Yuxuan Zhang; Zhengyan Weng; Lori Avery; Kevin D Dieckhaus; Advaith Peddi; Yang Gao; Yi Zhang; Xue Gao
Journal:  Nat Chem Biol       Date:  2022-09-22       Impact factor: 16.174

4.  Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variants.

Authors:  Pardis C Sabeti; Cameron Myhrvold; Jon Arizti-Sanz; A'Doriann Bradley; Yibin B Zhang; Chloe K Boehm; Catherine A Freije; Michelle E Grunberg; Tinna-Solveig F Kosoko-Thoroddsen; Nicole L Welch; Priya P Pillai; Sreekar Mantena; Gaeun Kim; Jessica N Uwanibe; Oluwagboadurami G John; Philomena E Eromon; Gregory Kocher; Robin Gross; Justin S Lee; Lisa E Hensley; Bronwyn L MacInnis; Jeremy Johnson; Michael Springer; Christian T Happi
Journal:  Nat Biomed Eng       Date:  2022-05-30       Impact factor: 29.234

5.  Detection of SARS-CoV-2 in COVID-19 Patient Nasal Swab Samples Using Signal Processing.

Authors:  Mahmoud Al Ahmad; Lillian J A Olule; Mohammed Meetani; Farrukh Amin Sheikh; Rahima Al Blooshi; Neena G Panicker; Farah Mustafa; Tahir A Rizvi
Journal:  IEEE J Sel Top Signal Process       Date:  2021-12-09       Impact factor: 7.695

6.  Programmable CRISPR-Cas9 microneedle patch for long-term capture and real-time monitoring of universal cell-free DNA.

Authors:  Bin Yang; Jilie Kong; Xueen Fang
Journal:  Nat Commun       Date:  2022-07-09       Impact factor: 17.694

7.  Rapid, adaptable and sensitive Cas13-based COVID-19 diagnostics using ADESSO.

Authors:  Beatrice Casati; Joseph Peter Verdi; Alexander Hempelmann; Maximilian Kittel; Andrea Gutierrez Klaebisch; Bianca Meister; Sybille Welker; Sonal Asthana; Salvatore Di Giorgio; Pavle Boskovic; Ka Hou Man; Meike Schopp; Paul Adrian Ginno; Bernhard Radlwimmer; Charles Erec Stebbins; Thomas Miethke; Fotini Nina Papavasiliou; Riccardo Pecori
Journal:  Nat Commun       Date:  2022-06-08       Impact factor: 17.694

Review 8.  Development of clustered regularly interspaced short palindromic repeats/CRISPR-associated technology for potential clinical applications.

Authors:  Yue-Ying Huang; Xiao-Yu Zhang; Ping Zhu; Ling Ji
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

9.  Designing sensitive viral diagnostics with machine learning.

Authors:  Hayden C Metsky; Nicole L Welch; Priya P Pillai; Nicholas J Haradhvala; Laurie Rumker; Sreekar Mantena; Yibin B Zhang; David K Yang; Cheri M Ackerman; Juliane Weller; Paul C Blainey; Cameron Myhrvold; Michael Mitzenmacher; Pardis C Sabeti
Journal:  Nat Biotechnol       Date:  2022-03-03       Impact factor: 68.164

10.  A field-deployable method for single and multiplex detection of DNA or RNA from pathogens using Cas12 and Cas13.

Authors:  Lina Li; Canxing Duan; Jianfeng Weng; Xiantao Qi; Changlin Liu; Xinhai Li; Jinjie Zhu; Chuanxiao Xie
Journal:  Sci China Life Sci       Date:  2021-12-23       Impact factor: 10.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.